MK‐329: A non‐peptide cholecystokinin a antagonist
- 1 August 1993
- journal article
- Published by Wiley in Drug Development Research
- Vol. 29 (4), 255-261
- https://doi.org/10.1002/ddr.430290402
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Medicinal Chemistry in the Golden Age of Biology: Lessons from Steroid and Peptide ResearchAngewandte Chemie International Edition in English, 1991
- Characterization of MK-329Published by Springer Nature ,1991
- A new potent and selective non-peptide gastrin antagonist and brain cholecystokinin receptor (CCK-B) ligand: L-365,260European Journal of Pharmacology, 1989
- Benzodiazepine gastrin and brain cholecystokinin receptor ligands; L-365,260Journal of Medicinal Chemistry, 1989
- Methods for drug discovery: development of potent, selective, orally effective cholecystokinin antagonistsJournal of Medicinal Chemistry, 1988
- Design of nonpeptidal ligands for a peptide receptor: cholecystokinin antagonistsJournal of Medicinal Chemistry, 1987
- A new simple mouse model for the in vivo evaluation of cholecystokinin (CCK) antagonists: Comparative potencies and durations of action of nonpeptide antagonistsLife Sciences, 1986
- Design of potent, orally effective, nonpeptidal antagonists of the peptide hormone cholecystokinin.Proceedings of the National Academy of Sciences, 1986
- A potent nonpeptide cholecystokinin antagonist selective for peripheral tissues isolated from Aspergillus alliaceusScience, 1985
- Synthesis and receptor binding studies relevant to the neuroleptic activities of some 1-methyl-4-piperidylidene-9-substituted-pyrrolo[2,1-b][3]benzazepine derivativesJournal of Medicinal Chemistry, 1983